Mitral Leaflet Shortening as an Ancillary Procedure in Obstructive Hypertrophic Cardiomyopathy

Daniel G Swistel1, Daniele Massera2, Alexandra Stepanovic2

  • 1Department of Cardiothoracic Surgery, NYU School of Medicine, New York, New York.

PubMed

Insights

Mitral leaflet shortening combined with myectomy in hypertrophic cardiomyopathy (HCM) patients showed similar survival and echocardiographic outcomes compared to myectomy alone. This suggests leaflet shortening is a safe and effective adjunct for selected HCM patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Research

Background:

  • Mitral leaflet elongation is common in hypertrophic cardiomyopathy (HCM), complicating surgical goals.
  • Anterior mitral leaflet shortening during myectomy is a controversial ancillary procedure.

Purpose of the Study:

  • To compare the outcomes of myectomy with concomitant mitral leaflet shortening versus myectomy alone in HCM patients.
  • To evaluate the safety and efficacy of evolving mitral shortening techniques (plication vs. ReLex).

Main Methods:

  • Retrospective study of 416 patients undergoing myectomy (2010-2020).
  • Comparison of outcomes between patients receiving myectomy with mitral shortening and those receiving myectomy alone.
  • Analysis of survival and echocardiographic data, including evolving mitral shortening techniques.

Main Results:

  • Hospital mortality was 0.7%.
  • At 8 years, cumulative survival was 95% for both groups (myectomy with leaflet shortening vs. myectomy alone), with no significant difference.
  • Echocardiography at 2.5 years showed similar reductions in gradients, mitral regurgitation, and left atrial volume between groups.

Conclusions:

  • Mitral shortening is an appropriate surgical consideration for selected HCM patients.
  • The study supports the use of mitral leaflet shortening as an adjunct to myectomy.
  • No significant difference in survival or echocardiographic outcomes was observed between leaflet shortening techniques.
Abstract

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...